TP53 and ovarian cancer: Our finding that restoration of p53 had no significant effect on its physical binding to both p65 and IκB in ovarian cancer cells tested (Figure 5B) suggests that p53 binding to these components of NF-κB does not likely contribute to its inhibition of NF-κB activity.